Abstract:Atherosclerosis (AS) leads to atherosclerotic cardiovascular disease (ASCVD), the predominant cause of death worldwide. As traditional lipid-lowering therapies have encountered a bottleneck in dealing with diverse types of atherosclerotic plaques and ASCVD, alternative therapies that can target other mechanisms are urgently needed. Recent studies have revealed that AS is rooted in disrupted immune responses, such as chronic local inflammation and autoimmune responses, and immunotherapies have emerged as a nascent avenue to control plaque development owing to their satisfactory effects and high cost efficiency. The atherosclerotic immune microenvironment (AIME) is the microenvironment in which diverse immune responses occur dynamically. AIME is characterized by persistent inflammatory responses, shifted immunometabolism, and the formation of adventitial neuroimmune cardiovascular interfaces, all of which are regarded as prospective targets for AS immunotherapy. Recently, the advent of nanotechnology has advanced AS immunotherapy targeting the AIME. Manifold nanoplatforms have greatly enriched AS therapeutics owing to their multimodal imaging and multichannel intervention capabilities. Here, we offer an overview of AIME and discuss how nanomedicines can assist in AS diagnosis and intervention. We introduce nanoplatforms integrated with imaging techniques, such as magnetic resonance imaging, photoacoustic imaging, fluorescence imaging, positron emission tomography, and ultrasound imaging, which can target AIME to realize plaque diagnosis. Moreover, we elaborated on nanomaterials that regulate innate immune responses, adaptive immune responses, and aberrant immunometabolism to achieve AIME modulation. Furthermore, we highlight the possible future directions of AS therapeutics, with a focus on AIME-targeted nanomedicines.

Progress and Perspective of Atherosclerosis-Targeted Molecular Probes: from Precise Imaging to Auxiliary Diagnosis and Treatment

Advances of Optical Probes in Atherosclerosis Imaging

Detection and Imaging of Active Substances in Early Atherosclerotic Lesions using Fluorescent Probes

Targeted Imaging in Atherosclerosis.

Activatable fluorescent probes for atherosclerosis theranostics

Molecular imaging nanoprobes and their applications in atherosclerosis diagnosis

Fluorescent probes for imaging: a focus on atherosclerosis

Advances in nano-delivery systems based on diagnosis and theranostics strategy for atherosclerosis

Recent Advances in Lipid-responsive Probes in the Imaging and Treatment of Atherosclerosis

Recent Advances in Molecular Imaging of Atherosclerotic Plaques and Thrombosis

Intravascular molecular imaging: translating pathophysiology of atherosclerosis into human disease conditions

Shedding New Light on Atherosclerosis Therapeutics: Nanomedicines Targeting Atherosclerotic Immune Microenvironment

Molecular Imaging and Non-molecular Imaging of Atherosclerotic Plaque Thrombosis

Omics research in atherosclerosis

New Progress of Image Technique in Atherosclerosis

Atherosclerosis imaging on the molecular level

Molecular magnetic resonance imaging of atherosclerosis

Recent progress in biomimetic nanomedicines based on versatile targeting strategy for atherosclerosis therapy

New Progress in Early Diagnosis of Atherosclerosis

Emerging Nanoprobes for the Features Visualization of Vulnerable Atherosclerotic Plaques

Current targeting strategies and advanced nanoplatforms for atherosclerosis therapy